Clinical trial
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
NCT02843230 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2016
- Completion date
- January 31, 2022
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.